Sandra Levy
ARTICLES BY THIS AUTHOR
- 10/23/2019
IPC inks deal with Vials.com, extends partnership with Kodak Moments
Through Vials.com, and Kodak Moments, IPC is offering its members additional benefits. . - 10/23/2019
H-E-B names PrescribeWellness 2019 Service Vendor of the Year
PrescribeWellness is being recognized by H-E-B for its continued dedication to empower community pharmacy. - 10/22/2019
Health Mart pharmacies join ranks of Amazon Counter package pickup locations
Amazon Counter pickup points now include Health Mart pharmacies, GNC and Stage Stores. - 10/22/2019
Bryn partners with Aptra for nasal epinephrine treatment
Aptar's Bidose device delivers two therapeutic doses of epinephrine, replacing the need to carry two epinephrine auto-injectors. - 10/21/2019
CVS Health expands safe medication disposal program in Massachusetts
CVS Health has completed installation of 56 safe medication disposal kiosks in select CVS Pharmacy locations in communities across Massachusetts. - 10/21/2019
AmerisourceBergen partners with UPS Flight Forward to transport medical products via drone
AmerisourceBergen is planning to transport via drone certain pharmaceuticals, supplies and records to qualifying medical campuses, and will later expand to other sites of care. - 10/21/2019
Alembic's Aleor joint venture gets FDA approval for generic Clobex
Clobetasol propionate spray, 0.05%, had a market value of roughly $22 million for the 12 months ended December 2018, according to IQVIA. - 10/21/2019
FDA approves Teligent’s gentamicin sulfate cream
Gentamicin sulfate cream, 0.1% has a market value of roughly $15.6 million, according to IQVIA October data. - 10/21/2019
Foamix reaches litigation settlement with Teva on Finacea Foam
Foamix and LEO Pharma have reached a settlement agreement with Teva on patent litigation involving Finacea Foam. It follows a settlement in April with Perrigo. - 10/21/2019
FDA generic approvals reached a record high in fiscal year 2019
In fiscal year 2019, the FDA approved a total of 1,171 generic drug approvals, which comprised 935 full approvals and 236 tentative approvals.
